Progyny, Inc. PGNY · NASDAQ
$27.84 +3.65% (+$0.98)
Summary
77 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 29% a year over the last 3 years.
- It holds more cash than debt: $152.6M against $27.0M.
- It earns 15 USD a year on every 100 USD of invested capital.
- Out of every 100 USD of revenue, 17 USD is left as free cash.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 26.2 USD for 1 USD of yearly profit. Over the last five years it was 61.9 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 30% a year over 5 years. Over the last 3 years it grew by 18% a year. For the next fiscal year analysts expect revenue to grow by 6.7%. Earnings per share grew by 29% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 75 USD
- Sales and administration 16 USD
- Taxes and other 2.6 USD
- Net profit 6.0 USD
Net profit, industry median (Medical - Healthcare Plans) 2.3 USD
Out of every 100 USD of revenue, 6.0 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 14
- Hold 6
- Sell 0
Today's price within the analysts' price targets
The average target of $35.5 is 28% above today's price. 70% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Fertility benefit services revenue 64%
- Pharmacy benefit services revenue 36%
By region
The company reports no revenue by region.
Fertility benefit services revenue brings in 64% of revenue. Pharmacy benefit services revenue grew fastest, by 33% a year.
Segments in detail